GABBR1 and Alzheimer disease: The 17A cells have been shown to downregulate the expression of GABA-B receptors and deactivate the GABA-B signaling cascade in AD mouse models [244,246], implying their potential relevance in the neuroinflammatory processes involved in AD pathophysiology, which must be further explored.